Microbial superantigens and exotoxins may further contribute to tumor progression and therapeutic resistance by reinforcing JAK/STAT signaling, particularly STAT3, and reducing CD8+ T-cell-mediated immune surveillance. The gene discussed is CD8A; the disease is neoplasm.